Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Strictly Pharmaceuticals ApS
APS
In liquidation
Advertising protection
CVR 42088838
Maglehøj 15, 3520
Farum
Investeringsselskaber
·
NACE 643030
Est. 2021 · 5 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Investeringsselskaber
/
Strictly Pharmaceuticals ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
0M
0M
-1M
-1M
0M
2021
0M
0%
2022
EBITDA
DKK millions
0M
0M
0M
-1M
-1M
0M
2021
0M
0%
2022
Income statement
DKK thousands
Item
2021
2022
Revenue
0
—
Staff expenses
-0
-0
EBITDA
-49
-1
Depreciation & amort.
-0
-0
EBIT
-49
-1
Net financials
0
0
Profit before tax
-49
-1
Tax
-6
-0
Net profit
-43
-1
Balance sheet
DKK thousands
Item
2021
2022
Total assets
7
6
Equity
7
6
Long-term debt
0
0
Short-term debt
0
0
Total debt
0
0
Financial ratios
5-year trend
EBITDA margin
-68100.0%
This company
15.8%
Market median
431113% below market
2021
2022
Equity ratio
100.0%
This company
38.2%
Market median
162% above market
2021
2022
Return on equity
-11.4%
This company
18.4%
Market median
162% below market
2021
2022
Net profit margin
-68100.0%
This company
8.1%
Market median
840841% below market
2021
2022
Asset turnover
0.00×
This company
1.12×
Market median
100% below market
2021
2022
Debt / equity
0.00×
This company
0.62×
Market median
100% below market
2021
2022
Annual reports & filings
Annual report 2022
Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-31 – 2021-09-30
View
PDF
More on Strictly Pharmaceuticals ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
